Atrium Innovations Inc. — Investor Relations & Filings
Filings indexed
66
across all filing types
Latest filing
2011-08-12
Regulatory Filings
Country
CA
Canada
Listing
TSX
ATB
Atrium Innovations Inc. is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products. The company's portfolio primarily consists of nutritional and dietary supplements, including specialized products, vitamins, and minerals, alongside certain cosmetic and chemical formulations. Atrium focuses on delivering professionally endorsed solutions that support a holistic approach to individualized health and healing. A key component of its operations includes providing educational resources, such as expert-led webinars, focused on advancing knowledge in natural medicine and nutrition science for healthcare practitioners.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - French.pdf | 2011-08-12 | English | |
| Decision Document (Final).pdf | 2011-07-29 | English | |
| Consent letter of underwriters' legal counsel.pdf | 2011-07-29 | English | |
| Decision Document (Preliminary).pdf | 2011-07-21 | English | |
| Preliminary short form prospectus – English.pdf | 2011-07-21 | English | |
| Other securityholders documents - English.pdf | 2011-07-21 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2011
10 filings
| |||||
| 47172260 | Material change report - French.pdf | 2011-08-12 | English | ||
| 47172263 | Decision Document (Final).pdf | 2011-07-29 | English | ||
| 47172266 | Consent letter of underwriters' legal counsel.pdf | 2011-07-29 | English | ||
| 47172280 | Decision Document (Preliminary).pdf | 2011-07-21 | English | ||
| 47172282 | Preliminary short form prospectus – English.pdf | 2011-07-21 | English | ||
| 47172311 | Other securityholders documents - English.pdf | 2011-07-21 | English | ||
| 47172343 | Annual information form - French.pdf | 2011-04-01 | English | ||
| 47172349 | Material change report - English.pdf | 2011-03-08 | English | ||
| 47172353 | Other.pdf | 2011-01-10 | English | ||
| 47172373 | Material change report - English.pdf | 2011-01-10 | English | ||
|
2010
5 filings
| |||||
| 47172377 | Other.pdf | 2010-12-21 | English | ||
| 47172762 | Material change report - French.pdf | 2010-12-21 | English | ||
| 47172765 | Annual information form - French.pdf | 2010-03-31 | English | ||
| 47172780 | Other.pdf | 2010-03-23 | English | ||
| 47172786 | Other.pdf | 2010-03-23 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Atrium Innovations Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45568/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45568 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45568 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45568 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45568}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Atrium Innovations Inc. (id: 45568)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.